Почетна › Рак јајника › Kalifornija › Los Angeles
Kliničke studije za Рак јајника u gradu Los Angeles, CA
53 studija za Рак јајника traži učesnike na lokacijama u gradu Los Angeles i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Тражи се учесникФаза 2/3
- Cedars-Sinai Medical Center, Los Angeles
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
Тражи се учесникФаза 1/2
- South Texas Accelerated Research Therapeutics START LLC, Los Angeles
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Тражи се учесникФаза 2
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Тражи се учесникФаза 2
- Cedars Sinai Medical Center, Los Angeles
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Тражи се учесник
- Keck Medicine of USC Koreatown, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- и још 3
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- University of California - Los Angeles, Los Angeles
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
Тражи се учесникНаводи исплату за учеснике
- University of California Los Angeles (UCLA), Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Тражи се учесникФаза 3
- UCLA Hematology/Oncology - Westwood (Building 100), Los Angeles
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- University of California Los Angeles Medical Center, Los Angeles
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Тражи се учесникФаза 1
- START Los Angeles, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 2
- USA06-0, Los Angeles
- USA16-0, Los Angeles
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Тражи се учесникФаза 1/2
- VA Greater Los Angeles Healthcare System, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- Los Angeles Cancer Network, Los Angeles
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Тражи се учесникФаза 2
- UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Тражи се учесникФаза 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
- и још 1
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Тражи се учесникФаза 3
- Valkyrie Clinical Trials, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, Los Angeles
A Study of PHST001 in Advanced Solid Tumors
Тражи се учесникФаза 1
- USC Norris Comprehensive Cancer Center, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Тражи се учесникФаза 2
- Start Los Angeles /ID# 281533, Los Angeles
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Тражи се учесникФаза 1
- Research Site, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Тражи се учесникФаза 2
- Research Site, Los Angeles
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Тражи се учесникФаза 2
- University of California, Los Angeles Medical Center, Los Angeles
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Southern California, Los Angeles
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
Тражи се учесникФаза 1/2
- Start Cal, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Тражи се учесникФаза 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Тражи се учесникФаза 1
- Valkyrie Clinical Trials, Los Angeles
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Тражи се учесникФаза 1
- START - Los Angeles, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- UCLA - Hematology/Oncology Clinical Research Unit, Los Angeles
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Тражи се учесникФаза 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Тражи се учесникФаза 1/2
- University of Southern California, Los Angeles
- UCLA, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Ellison Clinic at Saint John's, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
EXoPERT EMERALD Clinical Study
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- City of Hope Duarte Cancer Center, Los Angeles
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Тражи се учесникФаза 2
- GSK Investigational Site, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Тражи се учесникФаза 1/2
- UCLA Medical Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Тражи се учесникФаза 1
- Start Lacn, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Тражи се учесник
- Oncology Institute for Hope and Innovation, Los Angeles
Access to Genetic Testing in Underserved Patients With Cancer
Тражи се учесникЗдраве особе су добродошле
- USC / Norris Comprehensive Cancer Center, Los Angeles
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Тражи се учесникФаза 1
- UCLA - JCCC Clinical Research Unit, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Тражи се учесникФаза 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Тражи се учесникФаза 2
- UCLA - JCCC Clinical Research Unit, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Cedars Sinai Medical Center, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Тражи се учесникФаза 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- MiraKind, Los Angeles
Studije za Рак јајника u drugim gradovima
- Houston, TX90 студија
- New York City, NY75 студија
- Boston, MA62 студија
- Nashville, TN50 студија
- Arlington, VA47 студија
- Philadelphia, PA47 студија
- Columbus, OH39 студија
- St. Louis, MO37 студија
- Chicago, IL36 студија
- San Antonio, TX33 студија
- Pittsburgh, PA32 студија
- Dallas, TX31 студија
Ostale studije u gradu Los Angeles
- Немалоклетни карцином плућа92 студија
- Рак дојке73 студија
- Рак (све врсте)73 студија
- Рак простате64 студија
- Колоректални карцином61 студија
- Метастатски карцином57 студија
- Рак плућа45 студија
- Плоскоклеточни карцином главе и врата43 студија
- Рак панкреаса36 студија
- Карцином ендометријума35 студија
- Меланом34 студија
- Trostruko negativni rak dojke27 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.